                </a></li></ul></div><p><strong>Figure 5.  <span>Long-term histopathological changes after activation of hVEGF-A<sub>165</sub> expression.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>A. Liver: Dilated hepatic vein branches and mild dilatation of the sinuses (marked with *) (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p2" name="article1.body1.sec2.sec2.fig1.caption1.p2"></a><p>B. Liver: focal basophilic hyperplasia consisting of fat-filled hepatocytes (pointed with arrows), (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p3" name="article1.body1.sec2.sec2.fig1.caption1.p3"></a><p>C. Heart: epicardial calcification in ventricular myocardium (pointed with an arrow), (Haematoxylin-eosin, insert Alizarin RedS staining specific for calcium).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p4" name="article1.body1.sec2.sec2.fig1.caption1.p4"></a><p>D. Control heart. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p5" name="article1.body1.sec2.sec2.fig1.caption1.p5"></a><p>E. Heart: ventricular myocardium revealed discrete edema and dilatation of subepicardial vessels (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p6" name="article1.body1.sec2.sec2.fig1.caption1.p6"></a><p>F. Tuba uterina revealed high vascularization and focally dilated venules and arterioles (pointed with arrows), (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p7" name="article1.body1.sec2.sec2.fig1.caption1.p7"></a><p>G. Pancreas with focally increased vasculature (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p8" name="article1.body1.sec2.sec2.fig1.caption1.p8"></a><p>H. Control pancreas. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p9" name="article1.body1.sec2.sec2.fig1.caption1.p9"></a><p>I. Testes with increased and dilated vasculature (pointed with arrows), (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p10" name="article1.body1.sec2.sec2.fig1.caption1.p10"></a><p>J. Control testes. (CD 31 immunostaining). Bar: A, B, C, D, I,J - 200 µm, G, H, E- 100 µm, F- 500 µm.</p>
